the spectrum of anitmicrobial activity
action of antimicrobial drugs
mechanism of antibiotics action
inhibation of protein synthesis
quinolones
Antimeta metabolites
Antibiotics target bacteria and some other microorganisms. Broad-spectrum antibiotics affect a wide range of bacteria while narrow-spectrum antibiotics only target a few types. Antibiotics work by interfering with bacterial protein synthesis, membrane function, or nucleotide synthesis. Common side effects include diarrhea and nausea, while rare side effects include kidney stones or sensitivity to sunlight. Overuse of antibiotics has led to increased antibiotic resistance in disease-causing microbes.
The document discusses various molecular mechanisms of antibiotic resistance in bacteria. It describes 3 main categories of resistance mechanisms: 1) preventing access to antibiotic targets through reduced permeability or increased efflux, 2) modifying antibiotic targets by genetic mutation or target protection/modification, and 3) directly inactivating antibiotics through hydrolysis or chemical modification. Recent studies have greatly expanded understanding of resistance genes and mechanisms, which can inform new drug development and clinical use of antibiotics.
This document provides an overview of current antibiotic drugs, organized by their mechanism of action. It begins by introducing penicillins like benzylpenicillin and amoxicillin, noting the rise of resistance. It then discusses beta-lactamase inhibitors that are combined with penicillins. The document also covers cephalosporins, carbapenems, glycopeptides, sulfonamides, tetracyclines, aminoglycosides, macrolides, and other antibiotic classes. It provides examples of common drugs for each class and their typical uses. The document concludes by discussing new approaches to developing antibiotics that target bacterial virulence factors or inhibit cell surface protein secretion.
This document discusses different classifications and mechanisms of antimicrobial agents. It describes how antibiotics can be classified based on their chemical structure, source, mechanism of action, spectrum of activity, and mode of action. The main mechanisms of antibiotic resistance are discussed, including production of enzymes to destroy antibiotics and alterations to cell membranes or metabolic pathways. Approaches to addressing resistance include proper antibiotic usage and selection based on accurate diagnosis and susceptibility testing.
This document discusses the mechanisms of action of antimicrobial drugs. It explains that antimicrobials work by inhibiting microbial growth and multiplication through various targets, including the cell wall, cell membrane, protein synthesis, intermediary metabolism, and nucleic acid metabolism. It provides examples of specific drugs that act on these various targets, such as betalactams which inhibit cell wall synthesis, polymixins which disrupt the cell membrane, and fluoroquinolones which inhibit DNA gyrase. The document aims to describe how antimicrobials are able to selectively kill pathogens while sparing host cells.
To understand the mechanisms of antimicrobial action and the classification of antimicrobial drugs.
To explain the process of microbial resistance.
To understand the spread of resistant microbes.
Outlines the prevention of microbial resistance.
Antibiotics and their mode of action ankush (2019 a109m)ankushkanger1
Antibiotics are secondary metabolites produced by microorganisms that inhibit the growth of other microorganisms. Some key antibiotics include penicillin, discovered in 1928, and streptomycin, discovered in 1944. Antibiotics act through several modes of action including inhibition of cell wall synthesis, damage to cell membranes, and inhibition of protein and nucleic acid synthesis. Common classes of antibiotics include beta-lactams like penicillin which inhibit cell wall synthesis, macrolides like erythromycin which inhibit ribosomal translocation, and aminoglycosides like streptomycin which bind to ribosomal subunits and inhibit translocation. Each class has distinctive producers and modes of inhibitory action on bacterial growth and reproduction.
Chemotherapy uses chemicals to inhibit the growth of microorganisms and is used with other treatments like biological therapies, hormonal therapy, radiation therapy, and surgery. Antibiotics are produced by microorganisms and kill or inhibit the growth of other organisms. Chemotherapeutic agents target parasitic cells while being innocuous to host cells by exploiting biochemical differences between the parasite and host. There are three classes of biochemical reactions in bacteria that can be targeted: class I involves energy production, class II small molecule synthesis, and class III macromolecule assembly. Differences between bacterial and human cells allow some class III reactions like peptidoglycan cell wall synthesis to be targeted.
Antibiotics target bacteria and some other microorganisms. Broad-spectrum antibiotics affect a wide range of bacteria while narrow-spectrum antibiotics only target a few types. Antibiotics work by interfering with bacterial protein synthesis, membrane function, or nucleotide synthesis. Common side effects include diarrhea and nausea, while rare side effects include kidney stones or sensitivity to sunlight. Overuse of antibiotics has led to increased antibiotic resistance in disease-causing microbes.
The document discusses various molecular mechanisms of antibiotic resistance in bacteria. It describes 3 main categories of resistance mechanisms: 1) preventing access to antibiotic targets through reduced permeability or increased efflux, 2) modifying antibiotic targets by genetic mutation or target protection/modification, and 3) directly inactivating antibiotics through hydrolysis or chemical modification. Recent studies have greatly expanded understanding of resistance genes and mechanisms, which can inform new drug development and clinical use of antibiotics.
This document provides an overview of current antibiotic drugs, organized by their mechanism of action. It begins by introducing penicillins like benzylpenicillin and amoxicillin, noting the rise of resistance. It then discusses beta-lactamase inhibitors that are combined with penicillins. The document also covers cephalosporins, carbapenems, glycopeptides, sulfonamides, tetracyclines, aminoglycosides, macrolides, and other antibiotic classes. It provides examples of common drugs for each class and their typical uses. The document concludes by discussing new approaches to developing antibiotics that target bacterial virulence factors or inhibit cell surface protein secretion.
This document discusses different classifications and mechanisms of antimicrobial agents. It describes how antibiotics can be classified based on their chemical structure, source, mechanism of action, spectrum of activity, and mode of action. The main mechanisms of antibiotic resistance are discussed, including production of enzymes to destroy antibiotics and alterations to cell membranes or metabolic pathways. Approaches to addressing resistance include proper antibiotic usage and selection based on accurate diagnosis and susceptibility testing.
This document discusses the mechanisms of action of antimicrobial drugs. It explains that antimicrobials work by inhibiting microbial growth and multiplication through various targets, including the cell wall, cell membrane, protein synthesis, intermediary metabolism, and nucleic acid metabolism. It provides examples of specific drugs that act on these various targets, such as betalactams which inhibit cell wall synthesis, polymixins which disrupt the cell membrane, and fluoroquinolones which inhibit DNA gyrase. The document aims to describe how antimicrobials are able to selectively kill pathogens while sparing host cells.
To understand the mechanisms of antimicrobial action and the classification of antimicrobial drugs.
To explain the process of microbial resistance.
To understand the spread of resistant microbes.
Outlines the prevention of microbial resistance.
Antibiotics and their mode of action ankush (2019 a109m)ankushkanger1
Antibiotics are secondary metabolites produced by microorganisms that inhibit the growth of other microorganisms. Some key antibiotics include penicillin, discovered in 1928, and streptomycin, discovered in 1944. Antibiotics act through several modes of action including inhibition of cell wall synthesis, damage to cell membranes, and inhibition of protein and nucleic acid synthesis. Common classes of antibiotics include beta-lactams like penicillin which inhibit cell wall synthesis, macrolides like erythromycin which inhibit ribosomal translocation, and aminoglycosides like streptomycin which bind to ribosomal subunits and inhibit translocation. Each class has distinctive producers and modes of inhibitory action on bacterial growth and reproduction.
Chemotherapy uses chemicals to inhibit the growth of microorganisms and is used with other treatments like biological therapies, hormonal therapy, radiation therapy, and surgery. Antibiotics are produced by microorganisms and kill or inhibit the growth of other organisms. Chemotherapeutic agents target parasitic cells while being innocuous to host cells by exploiting biochemical differences between the parasite and host. There are three classes of biochemical reactions in bacteria that can be targeted: class I involves energy production, class II small molecule synthesis, and class III macromolecule assembly. Differences between bacterial and human cells allow some class III reactions like peptidoglycan cell wall synthesis to be targeted.
This document discusses antimicrobial resistance, which is one of the most important clinical problems today. It provides definitions of key terms like antibiotics, antimicrobials, and mechanisms of antibiotic resistance. The document also summarizes how resistance has developed and spread for certain microbes like MRSA and describes various mechanisms that bacteria use to develop resistance, such as modifying drug targets, inactivating antibiotics, or limiting drug uptake.
This document provides an overview of antibiotics, including:
1) It outlines the objectives of classifying commonly used antibiotics into six major classes, understanding their mechanisms of action, clinical uses, and side effects.
2) It summarizes the key characteristics and clinical uses of beta-lactams, aminoglycosides, fluoroquinolones, macrolides, tetracyclines, glycopeptides, and metronidazole.
3) It emphasizes the importance of considering pharmacokinetics and the site of infection when selecting an antibiotic to ensure it reaches the infection.
This document discusses antibiotic resistance mechanisms. It defines antimicrobial resistance (AMR) as when microbes become insensitive to medicines, making infections harder to treat. AMR occurs through two main mechanisms: acquired resistance, where bacteria gain resistance genes, usually through overuse of antibiotics creating selective pressure; and intrinsic resistance, where bacteria innately resist certain drug classes. Bacteria develop resistance via decreased permeability, efflux pumps, enzymatic inactivation of drugs like beta-lactamases, and modifying drug targets. Resistance can be transmitted between bacteria through mutation or mobile genetic elements like plasmids.
The document discusses antimicrobial drug resistance (AMDR) and the mechanisms by which microbes develop resistance to antimicrobial medications. It describes classes of AMDR including resistance to antifungal, antiviral, antiprotozoal, and antibacterial drugs. Mechanisms of resistance include altering drug receptors or targets, reducing drug accumulation in cells, inactivating drugs, and developing resistant metabolic pathways. The document also summarizes the cellular and molecular mechanisms of antimicrobial action, including interfering with cell wall synthesis, plasma membrane integrity, nucleic acid synthesis, ribosomal function, and folate synthesis.
This document discusses antimicrobials and their uses. It defines antimicrobials as substances that reduce microbes like bacteria and molds. Antimicrobial drugs are classified based on the microorganisms they target or their function. Broad spectrum antimicrobials affect many types of microbes while narrow spectrum drugs target specific microbes. The document also discusses antimicrobial resistance and how microbes develop resistance. It provides streptomycin as an example antimicrobial drug, describing its discovery, mode of action in inhibiting protein synthesis, and production process. Streptomycin is derived from bacteria and was an early antibiotic used to treat tuberculosis. The document concludes that while antimicrobials are useful, their overuse can lead to increased antimicrobial resistance in micro
Polypeptide antibiotics are a diverse class of natural antibiotics composed of amino acids joined by amide bonds. They are low molecular weight cationic polypeptides that act as powerful bactericidal agents against both gram-positive and gram-negative bacteria. Examples include gramicidin, bacitracin, polymyxin-B, and colistin. These antibiotics act by disrupting bacterial membranes through detergent-like and pseudophore formation mechanisms, leading to ion leakage and inactivation of endotoxins. In addition, chloramphenicol, vancomycin, and novobiocin are classified as miscellaneous antibiotics that have bactericidal properties through inhibition of protein synthesis or bacterial cell wall synthesis.
This document discusses systemic acquired resistance (SAR), a plant defense mechanism that confers broad-spectrum and long-lasting protection against pathogens. SAR involves the signal molecule salicylic acid and accumulation of pathogenesis-related proteins. It provides an alternative to hazardous chemical pesticides and has potential for sustainable agriculture. SAR is induced by necrotic pathogens and results in resistance throughout the plant via a signal transduction pathway involving salicylic acid.
This document discusses antimicrobial drugs, including antibiotics. It describes how antibiotics are substances produced by microorganisms that inhibit the growth of other microbes. It outlines several antibiotic-producing microorganisms and explains the mechanisms of action of antimicrobial drugs, including inhibiting cell wall synthesis, protein synthesis, and nucleic acid synthesis. The document also discusses the spectrum of antimicrobial activity and lists some common side effects and safety concerns with antimicrobial use, such as toxicity, resistance, and interaction with other drugs.
Antimicrobial agents and mechanisms of action 2Bruno Mmassy
This document discusses antimicrobial resistance and its mechanisms. It defines antimicrobial resistance and describes how it can arise through mutation or acquisition of genes. It covers various mechanisms of resistance such as production of inactivating enzymes, decreased permeability, efflux pumps, and modification of drug targets. It also discusses specific examples of resistance to beta-lactams, glycopeptides, and antibiotics that inhibit protein synthesis. Key terms related to drug-resistant organisms are defined.
This document discusses antimicrobial agents and chemotherapy. It begins by defining antibiotics as natural substances produced by microorganisms that suppress or kill other microorganisms. It then discusses antimicrobial agents, which include both naturally obtained and synthetic drugs that can attenuate microorganisms. Finally, it defines chemotherapeutic agents as drugs designed to inhibit or kill an infecting organism with minimal effect on the recipient. The document goes on to provide details on the classification, mechanisms, principles, development and prevention of antimicrobial resistance.
Relative or complete lack of effect of antimicrobial agent against a previously susceptible microbe/pathogen.
It is an evolutionary principal that organism adopt genetically to change in their environment.
since the doubling time of bacteria can be as short as 20 mnt, there may be many generations in even a few hours, providing ample opportunity for evolutionary adaptation.
The phenomenon of resistance imposes serious constraints on the options available for the treatment of many bacterial infections.
The resistance to chemotherapeutic agents can also develop in protozoa, in multicellular parasites and in population of malignant cells.
Today there are different strains of S. aureus resistant to almost every form of antibiotic in use.
12.COMPREHENSIVE OFANTIMICROBIAL AGENTS AND CHEMOTHERAPY ( CLASSIFICATION AND...Saminathan Kayarohanam
Antimicrobial Agents and Chemotherapy (AAC) features interdisciplinary studies that build our understanding of the underlying mechanisms and therapeutic applications of antimicrobial and antiparasitic agents and chemotherapy.
mechanism of resistance of antibiotics, ESBL, b lactums, enterobactericae, metallobactums, carbapenemases, types of mechanism of resistance, history of antibiotics and resistance
1. Antimicrobial resistance arises through genetic mutations and the acquisition of resistance genes from other bacteria.
2. Resistance genes can be acquired horizontally via mobile genetic elements such as plasmids, leading to rapid spread.
3. Common resistance mechanisms include enzymatic inactivation of antibiotics, modification or protection of antibiotic targets, and efflux pumps that pump out antibiotics.
Antimicrobial agents and mechanisms of action 2Bruno Mmassy
The document discusses antibiotic resistance mechanisms in bacteria. It describes several key mechanisms:
1. Production of enzymes that inactivate antibiotics through destruction or modification. This includes beta-lactamases that break down beta-lactam antibiotics.
2. Decreased permeability of the cell membrane, preventing antibiotic penetration.
3. Active efflux of antibiotics from the bacterial cell via efflux pumps.
4. Modification of antibiotic target sites, such as altered penicillin-binding proteins or modifications to ribosomes.
Resistance can arise through mutation or acquisition of resistance genes via horizontal gene transfer. Multiple resistance mechanisms can provide high-level or multidrug resistance.
Multiple Drug Resistance and Antibiotic Misuse In English.Education Front
The report on Multiple Drug Resistance and Antibiotic Misuse.
By: Nadia Hassan, Chandni Yaqoob and Mudassar Iqbal.
School of Biological Sciences, University of the Punjab.
IMIPEN® 500 (imipenem/cilastatin) is a broad-spectrum carbapenem antibiotic used as empirical monotherapy for serious bacterial infections in intensive care unit (ICU) patients. It is effective against both aerobic and anaerobic bacteria, including multidrug-resistant strains. Common serious infections treated with IMIPEN® 500 in the ICU include pneumonia, bloodstream infections, and urinary tract infections. It is administered intravenously in doses ranging from 500 mg to 1000 mg every 6 to 8 hours, depending on infection severity and patient risk factors.
This document summarizes antibiotics and their mechanisms of action. It discusses how antibiotics were first coined by Waksman to refer to substances produced by microorganisms that inhibit or kill other microorganisms. It then describes the ideal properties of an antibacterial and provides classifications of antibiotics by origin (natural, semi-synthetic, synthetic) and mechanism of action (bactericidal, bacteriostatic). The document proceeds to explain various antibiotic targets and mechanisms in depth, including inhibition of cell wall synthesis, membrane synthesis, protein synthesis, nucleic acid formation, and metabolism. It also notes common antibiotic side effects and challenges in antibiotic research and treatment.
- Antibiotics selectively target microbial processes without harming human host cells. Proper antibiotic use and hand hygiene have improved patient outcomes.
- Many antibiotics are naturally produced by bacteria and fungi to inhibit competition. Major classes include penicillins, cephalosporins, aminoglycosides, tetracyclines, macrolides, and sulfonamides.
- Antibiotics work by inhibiting bacterial cell wall, protein, or nucleic acid synthesis. However, antibiotic resistance has emerged through various mechanisms and poses a growing challenge.
This document discusses antimicrobial agents and antibiotics. It defines antimicrobial agents as chemicals that treat infectious diseases by inhibiting or killing pathogens. Ideal antimicrobial agents kill or inhibit pathogens, are not harmful to the host, cause no allergic reactions, and remain effective after storage and in tissues. The document then discusses different classes of antibiotics based on their source, mechanism of action, and targets, including cell wall synthesis inhibitors like penicillin and vancomycin, protein synthesis inhibitors like tetracyclines and chloramphenicol, and nucleic acid synthesis inhibitors like sulfonamides. It also addresses resistance acquisition through intrinsic, mutational or acquired genetic means.
This document discusses antimicrobial resistance, which is one of the most important clinical problems today. It provides definitions of key terms like antibiotics, antimicrobials, and mechanisms of antibiotic resistance. The document also summarizes how resistance has developed and spread for certain microbes like MRSA and describes various mechanisms that bacteria use to develop resistance, such as modifying drug targets, inactivating antibiotics, or limiting drug uptake.
This document provides an overview of antibiotics, including:
1) It outlines the objectives of classifying commonly used antibiotics into six major classes, understanding their mechanisms of action, clinical uses, and side effects.
2) It summarizes the key characteristics and clinical uses of beta-lactams, aminoglycosides, fluoroquinolones, macrolides, tetracyclines, glycopeptides, and metronidazole.
3) It emphasizes the importance of considering pharmacokinetics and the site of infection when selecting an antibiotic to ensure it reaches the infection.
This document discusses antibiotic resistance mechanisms. It defines antimicrobial resistance (AMR) as when microbes become insensitive to medicines, making infections harder to treat. AMR occurs through two main mechanisms: acquired resistance, where bacteria gain resistance genes, usually through overuse of antibiotics creating selective pressure; and intrinsic resistance, where bacteria innately resist certain drug classes. Bacteria develop resistance via decreased permeability, efflux pumps, enzymatic inactivation of drugs like beta-lactamases, and modifying drug targets. Resistance can be transmitted between bacteria through mutation or mobile genetic elements like plasmids.
The document discusses antimicrobial drug resistance (AMDR) and the mechanisms by which microbes develop resistance to antimicrobial medications. It describes classes of AMDR including resistance to antifungal, antiviral, antiprotozoal, and antibacterial drugs. Mechanisms of resistance include altering drug receptors or targets, reducing drug accumulation in cells, inactivating drugs, and developing resistant metabolic pathways. The document also summarizes the cellular and molecular mechanisms of antimicrobial action, including interfering with cell wall synthesis, plasma membrane integrity, nucleic acid synthesis, ribosomal function, and folate synthesis.
This document discusses antimicrobials and their uses. It defines antimicrobials as substances that reduce microbes like bacteria and molds. Antimicrobial drugs are classified based on the microorganisms they target or their function. Broad spectrum antimicrobials affect many types of microbes while narrow spectrum drugs target specific microbes. The document also discusses antimicrobial resistance and how microbes develop resistance. It provides streptomycin as an example antimicrobial drug, describing its discovery, mode of action in inhibiting protein synthesis, and production process. Streptomycin is derived from bacteria and was an early antibiotic used to treat tuberculosis. The document concludes that while antimicrobials are useful, their overuse can lead to increased antimicrobial resistance in micro
Polypeptide antibiotics are a diverse class of natural antibiotics composed of amino acids joined by amide bonds. They are low molecular weight cationic polypeptides that act as powerful bactericidal agents against both gram-positive and gram-negative bacteria. Examples include gramicidin, bacitracin, polymyxin-B, and colistin. These antibiotics act by disrupting bacterial membranes through detergent-like and pseudophore formation mechanisms, leading to ion leakage and inactivation of endotoxins. In addition, chloramphenicol, vancomycin, and novobiocin are classified as miscellaneous antibiotics that have bactericidal properties through inhibition of protein synthesis or bacterial cell wall synthesis.
This document discusses systemic acquired resistance (SAR), a plant defense mechanism that confers broad-spectrum and long-lasting protection against pathogens. SAR involves the signal molecule salicylic acid and accumulation of pathogenesis-related proteins. It provides an alternative to hazardous chemical pesticides and has potential for sustainable agriculture. SAR is induced by necrotic pathogens and results in resistance throughout the plant via a signal transduction pathway involving salicylic acid.
This document discusses antimicrobial drugs, including antibiotics. It describes how antibiotics are substances produced by microorganisms that inhibit the growth of other microbes. It outlines several antibiotic-producing microorganisms and explains the mechanisms of action of antimicrobial drugs, including inhibiting cell wall synthesis, protein synthesis, and nucleic acid synthesis. The document also discusses the spectrum of antimicrobial activity and lists some common side effects and safety concerns with antimicrobial use, such as toxicity, resistance, and interaction with other drugs.
Antimicrobial agents and mechanisms of action 2Bruno Mmassy
This document discusses antimicrobial resistance and its mechanisms. It defines antimicrobial resistance and describes how it can arise through mutation or acquisition of genes. It covers various mechanisms of resistance such as production of inactivating enzymes, decreased permeability, efflux pumps, and modification of drug targets. It also discusses specific examples of resistance to beta-lactams, glycopeptides, and antibiotics that inhibit protein synthesis. Key terms related to drug-resistant organisms are defined.
This document discusses antimicrobial agents and chemotherapy. It begins by defining antibiotics as natural substances produced by microorganisms that suppress or kill other microorganisms. It then discusses antimicrobial agents, which include both naturally obtained and synthetic drugs that can attenuate microorganisms. Finally, it defines chemotherapeutic agents as drugs designed to inhibit or kill an infecting organism with minimal effect on the recipient. The document goes on to provide details on the classification, mechanisms, principles, development and prevention of antimicrobial resistance.
Relative or complete lack of effect of antimicrobial agent against a previously susceptible microbe/pathogen.
It is an evolutionary principal that organism adopt genetically to change in their environment.
since the doubling time of bacteria can be as short as 20 mnt, there may be many generations in even a few hours, providing ample opportunity for evolutionary adaptation.
The phenomenon of resistance imposes serious constraints on the options available for the treatment of many bacterial infections.
The resistance to chemotherapeutic agents can also develop in protozoa, in multicellular parasites and in population of malignant cells.
Today there are different strains of S. aureus resistant to almost every form of antibiotic in use.
12.COMPREHENSIVE OFANTIMICROBIAL AGENTS AND CHEMOTHERAPY ( CLASSIFICATION AND...Saminathan Kayarohanam
Antimicrobial Agents and Chemotherapy (AAC) features interdisciplinary studies that build our understanding of the underlying mechanisms and therapeutic applications of antimicrobial and antiparasitic agents and chemotherapy.
mechanism of resistance of antibiotics, ESBL, b lactums, enterobactericae, metallobactums, carbapenemases, types of mechanism of resistance, history of antibiotics and resistance
1. Antimicrobial resistance arises through genetic mutations and the acquisition of resistance genes from other bacteria.
2. Resistance genes can be acquired horizontally via mobile genetic elements such as plasmids, leading to rapid spread.
3. Common resistance mechanisms include enzymatic inactivation of antibiotics, modification or protection of antibiotic targets, and efflux pumps that pump out antibiotics.
Antimicrobial agents and mechanisms of action 2Bruno Mmassy
The document discusses antibiotic resistance mechanisms in bacteria. It describes several key mechanisms:
1. Production of enzymes that inactivate antibiotics through destruction or modification. This includes beta-lactamases that break down beta-lactam antibiotics.
2. Decreased permeability of the cell membrane, preventing antibiotic penetration.
3. Active efflux of antibiotics from the bacterial cell via efflux pumps.
4. Modification of antibiotic target sites, such as altered penicillin-binding proteins or modifications to ribosomes.
Resistance can arise through mutation or acquisition of resistance genes via horizontal gene transfer. Multiple resistance mechanisms can provide high-level or multidrug resistance.
Multiple Drug Resistance and Antibiotic Misuse In English.Education Front
The report on Multiple Drug Resistance and Antibiotic Misuse.
By: Nadia Hassan, Chandni Yaqoob and Mudassar Iqbal.
School of Biological Sciences, University of the Punjab.
IMIPEN® 500 (imipenem/cilastatin) is a broad-spectrum carbapenem antibiotic used as empirical monotherapy for serious bacterial infections in intensive care unit (ICU) patients. It is effective against both aerobic and anaerobic bacteria, including multidrug-resistant strains. Common serious infections treated with IMIPEN® 500 in the ICU include pneumonia, bloodstream infections, and urinary tract infections. It is administered intravenously in doses ranging from 500 mg to 1000 mg every 6 to 8 hours, depending on infection severity and patient risk factors.
This document summarizes antibiotics and their mechanisms of action. It discusses how antibiotics were first coined by Waksman to refer to substances produced by microorganisms that inhibit or kill other microorganisms. It then describes the ideal properties of an antibacterial and provides classifications of antibiotics by origin (natural, semi-synthetic, synthetic) and mechanism of action (bactericidal, bacteriostatic). The document proceeds to explain various antibiotic targets and mechanisms in depth, including inhibition of cell wall synthesis, membrane synthesis, protein synthesis, nucleic acid formation, and metabolism. It also notes common antibiotic side effects and challenges in antibiotic research and treatment.
- Antibiotics selectively target microbial processes without harming human host cells. Proper antibiotic use and hand hygiene have improved patient outcomes.
- Many antibiotics are naturally produced by bacteria and fungi to inhibit competition. Major classes include penicillins, cephalosporins, aminoglycosides, tetracyclines, macrolides, and sulfonamides.
- Antibiotics work by inhibiting bacterial cell wall, protein, or nucleic acid synthesis. However, antibiotic resistance has emerged through various mechanisms and poses a growing challenge.
This document discusses antimicrobial agents and antibiotics. It defines antimicrobial agents as chemicals that treat infectious diseases by inhibiting or killing pathogens. Ideal antimicrobial agents kill or inhibit pathogens, are not harmful to the host, cause no allergic reactions, and remain effective after storage and in tissues. The document then discusses different classes of antibiotics based on their source, mechanism of action, and targets, including cell wall synthesis inhibitors like penicillin and vancomycin, protein synthesis inhibitors like tetracyclines and chloramphenicol, and nucleic acid synthesis inhibitors like sulfonamides. It also addresses resistance acquisition through intrinsic, mutational or acquired genetic means.
This document discusses antimicrobial agents and antibiotics. It defines antimicrobial agents as chemicals that treat infectious diseases by inhibiting or killing pathogens. Ideal qualities of antimicrobial agents are listed. Antibiotics are defined as substances derived from microorganisms or produced synthetically that destroy or limit microbial growth. Various classifications of antibiotics are described based on their source, spectrum of activity, route of administration, and mechanism of action. The major mechanisms of action discussed are inhibition of cell wall synthesis, cell membrane function, protein synthesis, and nucleic acid synthesis. Bacterial resistance both intrinsic and acquired is also summarized.
Antibiotics are metabolites produced by organisms that kill or inhibit the growth of other organisms. There are several classes of antibiotics that work through different mechanisms such as inhibiting bacterial cell wall synthesis, protein synthesis, or nucleic acid synthesis. Resistance can develop when antibiotics are overused or misused, allowing bacteria to mutate or acquire resistance genes. Proper use and preventing overuse can help reduce antibiotic resistance.
The document discusses various aspects of antimicrobial drugs and antibiotic resistance. It defines key terms like antimicrobials, antibiotics, and describes different classes of antibiotics including their mechanisms of action and examples. It discusses factors that influence the effectiveness of antibiotics like spectrum of activity, toxicity and resistance development. It differentiates between acquired and intrinsic antibiotic resistance, and lists factors like overuse/misuse of drugs, poor infection control and inappropriate antibiotic usage as major causes of acquired antibiotic resistance.
Antibiotics are chemical substances that kill or inhibit the growth of microorganisms. They can be classified based on their source (natural, semisynthetic, synthetic), spectrum of activity (broad or narrow), or mechanism of action. Common mechanisms include inhibition of cell wall synthesis, protein synthesis, nucleic acid synthesis, and cell membrane function. Examples provided include penicillins, cephalosporins, carbapenems, glycopeptides, aminoglycosides, macrolides, quinolones, sulfonamides, and metronidazole.
Antibiotics can be categorized based on their mechanism of action, including those that inhibit protein synthesis, nucleic acid synthesis, and metabolism. Protein synthesis inhibitors include antibiotics that bind to the 30S or 50S ribosomal subunits, such as aminoglycosides, tetracyclines, chloramphenicol, and macrolides. Nucleic acid synthesis inhibitors include rifampin which inhibits RNA polymerase and quinolones which inhibit DNA gyrase. Antimetabolites like sulfonamides and trimethoprim inhibit steps in folic acid synthesis. Resistance can develop through various mechanisms such as altering the antibiotic target, inhibiting drug influx/efflux, or enzymatic inactivation.
Antimicrobial chemotherapy & bacterial resistance dr. ihsan alsaimarydr.Ihsan alsaimary
This document discusses antimicrobial chemotherapy and antibiotic principles. It covers the major classes of antibiotics including cell wall active agents, protein synthesis inhibitors, nucleic acid synthesis inhibitors, and metabolic pathway inhibitors. It describes their mechanisms of action, spectra of activity, and common resistance mechanisms. Key points covered include the importance of appropriate antibiotic usage to prevent resistance, factors influencing antibiotic choice, and definitions of antibiotic properties.
Antimicrobial chemotherapy & bacterial resistance dr. ihsan alsaimarydr.Ihsan alsaimary
This document discusses antimicrobial chemotherapy and antibiotic resistance. It provides definitions and principles related to antimicrobial agents, including their spectrum of activity, mechanisms of action against bacteria, and factors that influence antibiotic choice. The document addresses various classes of antibiotics like beta-lactams, glycopeptides, macrolides and their mechanisms. It also discusses concepts like minimum inhibitory concentration, combination therapy, and factors that can accelerate the development of antibiotic resistance.
Antimicrobial chemotherapy & bacterial resistance dr. ihsan alsaimarydr.Ihsan alsaimary
This document discusses antimicrobial chemotherapy and antibiotic principles. It covers the major classes of antibiotics including cell wall active agents, protein synthesis inhibitors, nucleic acid synthesis inhibitors, and metabolic pathway inhibitors. It describes their mechanisms of action, spectra of activity, and common resistance mechanisms. Key points covered include the importance of appropriate antibiotic usage to prevent resistance, factors influencing antibiotic choice, and definitions of antibiotic properties.
This document discusses antimicrobial agents and antibiotic resistance. It defines antimicrobial agents as chemicals that treat infectious diseases by inhibiting or killing pathogens. Ideal antimicrobial agents kill or inhibit pathogens without harming the host. The document then discusses different classes of antibiotics including their sources, mechanisms of action, and examples. It covers antibiotics that inhibit cell wall synthesis, cell membrane function, protein synthesis, and nucleic acid synthesis. The document concludes by discussing intrinsic and acquired antibiotic resistance in bacteria.
This document discusses various classes of antibiotics and their mechanisms of action. It describes five main mechanisms: inhibition of cell wall synthesis, inhibition of cell membrane function, inhibition of protein synthesis, and inhibition of nucleic acid synthesis. For each mechanism, it provides examples of antibiotic classes that act through that mechanism, such as beta-lactams that inhibit cell wall synthesis and aminoglycosides that inhibit protein synthesis. It also describes the sources, spectra of activity, and modes of action for many individual antibiotic drugs.
This document summarizes various topics related to antimicrobial drugs, including:
- A brief history of antimicrobial drug discovery from Paul Ehrlich's discovery of Salvarsan 606 to treat syphilis to the discovery of sulfa drugs and penicillin.
- Key terminology used to describe antimicrobial drugs and their mechanisms of action, including categories like bacteriostatic, bactericidal, broad spectrum, narrow spectrum, and synergism.
- The main mechanisms of action that antibiotics use to kill or inhibit bacteria, including disrupting cell walls, inhibiting protein synthesis, and inhibiting nucleic acid synthesis.
- Examples of major classes of antibiotics that act through these different mechanisms, such as penicillins
This document provides an overview of antibiotics, including their history, classification, mechanisms of action, and principles of administration. It discusses how antibiotics are classified based on their targets in bacteria and spectra of activity. Common antibiotics are also reviewed, along with how bacteria can develop resistance through modifications to antibiotic targets, altered uptake or efflux, and antibiotic inactivation through enzymes. Proper dosing, timing, route, and monitoring of patients are important to achieve the desired therapeutic effects of antibiotics.
Antibiotics are natural compounds produced by microorganisms that inhibit the growth of other microorganisms. They can be classified as bactericidal, killing bacteria, or bacteriostatic, preventing bacterial multiplication. Antibiotics exhibit selective toxicity by targeting microbes without harming host cells. Common mechanisms of action include inhibition of cell wall synthesis, alteration of cell membranes, inhibition of protein synthesis, and inhibition of nucleic acid synthesis.
Anti-infective agents are drugs designed to selectively target and kill invading microorganisms without harming the host's cells. Paul Ehrlich was the first scientist to develop a synthetic chemical with this property in the 1920s. Anti-infectives work by interfering with microbial cell walls, protein synthesis, DNA synthesis, or cell membranes. Their goal is to reduce microbial populations to levels the immune system can handle. Microbes can develop resistance by modifying drug targets or transport mechanisms. Careful dosing and limiting inappropriate use can help prevent resistance.
This document provides an overview of antimicrobials (also known as antibiotics). It defines antimicrobials and discusses their classification as bactericidal or bacteriostatic. The document outlines the history of antimicrobial discovery and discusses their sources, selective toxicity, and modes of action. Key topics covered include the classification of antibiotics based on chemical structure and mechanism of action, as well as details on specific classes of antibiotics like penicillins, cephalosporins, carbapenems, and others.
The document discusses anti-infective agents, which are drugs designed to selectively target and kill invading microorganisms without harming the host's cells. It provides a brief history of anti-infective development and outlines several mechanisms of action, including interfering with bacterial cell wall synthesis, protein synthesis, and DNA synthesis. The document also discusses anti-infective classification, acquiring resistance, treatment considerations, antibiotic classes, and specific aminoglycoside antibiotics.
This document provides guidance on developing effective presentation skills. It discusses the key steps in preparing and delivering a presentation, including planning the presentation by determining the audience and goals, preparing the content and structure, practicing with visual aids, and presenting confidently with eye contact and engagement. Specific tips are provided for each step, such as using bullet points and simple designs for slides, varying voice pitch for emphasis, and rehearsing thoroughly. Common challenges like lack of practice and confidence are also addressed, along with factors for a successful presentation like being over-prepared and knowing the topic well.
This document contains an index of topics related to biochemistry including diet, vitamins, energy metabolism, lipid metabolism, carbohydrate metabolism, protein metabolism, and molecular biology. The index lists over 75 sub-topics ranging from hem biosynthesis and porphyria to DNA structure, replication, and gene transcription.
Sentence structure II (run-on, comma splice, fragment)HandSome
The document discusses three types of sentence errors: run-on sentences, comma splices, and sentence fragments. Run-on sentences improperly connect two independent clauses without proper punctuation. Comma splices join two independent clauses with only a comma. Sentence fragments are incomplete sentences missing a subject, verb, or both. The document provides examples and explanations of each error and methods to correct them, such as using periods, semicolons, conjunctions, or turning one clause into a dependent clause.
The document discusses the 4 types of sentence structures: simple, compound, complex, and compound-complex. A simple sentence contains one independent clause. A compound sentence joins two independent clauses with a conjunction. A complex sentence contains one independent clause and at least one dependent clause. A compound-complex sentence contains at least two independent clauses and one or more dependent clauses. Examples are provided for each type of sentence structure.
Communication
Communication skills
Communication types
Communication styles
Communication types
Communication essential skills
Communication knowledge
Communication thinking
Communication ways
Communication levels
verbal Communication
nonverbal Communication
Self Disclosure
Parts of speech
Noun
Pronoun
Adverb
Adjective
Interjection
Conjunction
Articles
Uses of Articles
Types of noun
types of pronoun
Ajective types
Adverb of time manner
adverb of place
examples of articles
The document provides examples of how various prepositions are used with time, place, verbs, adjectives, and idiomatic expressions in English. It lists over 50 individual prepositions like "on", "in", "at", "to", "from", "by", etc. and provides context examples to illustrate their usage related to time, place, or with certain verbs, adjectives, or expressions. The prepositions covered indicate time, location, direction, possession, and relationships between objects, people, or ideas in the English language.
.Mascular system
types
muscles
charactersitics
function of muscle
classification of muscles
sarcoplasmic organelles
structure of msucles
how to name muscle
neck muscle
intrinsic back muscle
extrinsic back muscles
anterior compartment of thih muscle
hamstring group muscles
IM injection common sites
muscular tension
software
types of software
operating system
utility software
application software
working of application of different software
examples
famous software
word
excel
powerPoint
Homeostasis refers to the maintenance of a stable internal environment in the body. It involves negative feedback loops that counteract changes to keep properties like temperature and pH levels within normal ranges. The concept of homeostasis was introduced by Walter Cannon in 1930 and forms the basis of physiology. It works through a cyclical system of receptors that detect changes, a control center that activates effectors to correct deviations and restore balance. Most processes use negative feedback loops while some emergency responses employ positive feedback. Disruptions to homeostasis can cause illness.
Hormones are chemical messengers secreted by endocrine glands directly into the bloodstream to regulate bodily functions. The major endocrine glands include the pituitary gland, thyroid gland, adrenal glands, pancreas, testes and ovaries. Hormones function through a process of biosynthesis in endocrine tissues, storage and secretion, transport through blood to target cells, recognition by cell receptors, signal transduction, cellular response, and hormone breakdown. Hormones are classified as steroid hormones, peptide hormones, or amino acid-derived hormones based on their chemical structure and include molecules like insulin, growth hormone, and thyroxine.
The document discusses the auditory ossicles, which are three small bones in the middle ear - the malleus, incus, and stapes. It describes the role of each bone in transmitting sound vibrations from the eardrum to the inner ear. The malleus is attached to the eardrum and transmits vibrations to the incus, which then passes them to the stapes to reach the inner ear. Together, the three bones mechanically transmit sound through a chain reaction of vibrations. The ossicles also help regulate loud sounds by contracting muscles that reduce the eardrum's vibration. Disorders can occur from conditions like otosclerosis or genetic disorders.
This document discusses the nutritional classification of bacteria into three main categories:
1) Photoheterotrophs, which use light energy but cannot use CO2 as their sole carbon source and obtain energy from organic compounds. Purple non-sulphur bacteria are examples.
2) Chemoheterotrophs, which obtain carbon and energy from organic compounds like glucose. There are saprophytic, parasitic, and symbiotic chemoheterotrophs.
3) Saprophytic bacteria obtain nutrients from decaying organic matter by secreting enzymes. Parasitic bacteria cause diseases in plants and animals. Symbiotic bacteria like nitrogen-fixing rhizobia live in plants and provide fixed nitrogen in exchange
The Ultimate Guide in Setting Up Market Research System in Health-TechGokul Rangarajan
How to effectively start market research in the health tech industry by defining objectives, crafting problem statements, selecting methods, identifying data collection sources, and setting clear timelines. This guide covers all the preliminary steps needed to lay a strong foundation for your research.
"Market Research it too text-booky, I am in the market for a decade, I am living research book" this is what the founder I met on the event claimed, few of my colleagues rolled their eyes. Its true that one cannot over look the real life experience, but one cannot out beat structured gold mine of market research.
Many 0 to 1 startup founders often overlook market research, but this critical step can make or break a venture, especially in health tech.
But Why do they skip it?
Limited resources—time, money, and manpower—are common culprits.
"In fact, a survey by CB Insights found that 42% of startups fail due to no market need, which is like building a spaceship to Mars only to realise you forgot the fuel."
Sudharsan Srinivasan
Operational Partner Pitchworks VC Studio
Overconfidence in their product’s success leads founders to assume it will naturally find its market, especially in health tech where patient needs, entire system issues and regulatory requirements are as complex as trying to perform brain surgery with a butter knife. Additionally, the pressure to launch quickly and the belief in their own intuition further contribute to this oversight. Yet, thorough market research in health tech could be the key to transforming a startup's vision into a life-saving reality, instead of a medical mishap waiting to happen.
Example of Market Research working
Innovaccer, founded by Abhinav Shashank in 2014, focuses on improving healthcare delivery through data-driven insights and interoperability solutions. Before launching their platform, Innovaccer conducted extensive market research to understand the challenges faced by healthcare organizations and the potential for innovation in healthcare IT.
Identifying Pain Points: Innovaccer surveyed healthcare providers to understand their difficulties with data integration, care coordination, and patient engagement. They found widespread frustration with siloed systems and inefficient workflows.
Competitive Analysis: Analyzed competitors offering similar solutions in healthcare analytics and interoperability. Identified gaps in comprehensive data aggregation, real-time analytics, and actionable insights.
Regulatory Compliance: Ensured their platform complied with HIPAA and other healthcare data privacy regulations. This compliance was crucial to gaining trust from healthcare providers wary of data security issues.
Customer Validation: Conducted pilot programs with several healthcare organizations to validate the platform's effectiveness in improving care outcomes and operational efficiency. Gathered feedback to refine features and user interface.
Mental Health and well-being Presentation. Exploring innovative approaches and strategies for enhancing mental well-being. Discover cutting-edge research, effective strategies, and practical methods for fostering mental well-being.
English Drug and Alcohol Commissioners June 2024.pptxMatSouthwell1
Presentation made by Mat Southwell to the Harm Reduction Working Group of the English Drug and Alcohol Commissioners. Discuss stimulants, OAMT, NSP coverage and community-led approach to DCRs. Focussing on active drug user perspectives and interests
Joker Wigs has been a one-stop-shop for hair products for over 26 years. We provide high-quality hair wigs, hair extensions, hair toppers, hair patch, and more for both men and women.
2024 Media Preferences of Older Adults: Consumer Survey and Marketing Implica...Media Logic
When it comes to creating marketing strategies that target older adults, it is crucial to have insight into their media habits and preferences. Understanding how older adults consume and use media is key to creating acquisition and retention strategies. We recently conducted our seventh annual survey to gain insight into the media preferences of older adults in 2024. Here are the survey responses and marketing implications that stood out to us.
Health Tech Market Intelligence Prelim Questions -Gokul Rangarajan
The Ultimate Guide to Setting up Market Research in Health Tech part -1
How to effectively start market research in the health tech industry by defining objectives, crafting problem statements, selecting methods, identifying data collection sources, and setting clear timelines. This guide covers all the preliminary steps needed to lay a strong foundation for your research.
This lays foundation of scoping research project what are the
Before embarking on a research project, especially one aimed at scoping and defining parameters like the one described for health tech IT, several crucial considerations should be addressed. Here’s a comprehensive guide covering key aspects to ensure a well-structured and successful research initiative:
1. Define Research Objectives and Scope
Clear Objectives: Define specific goals such as understanding market needs, identifying new opportunities, assessing risks, or refining pricing strategies.
Scope Definition: Clearly outline the boundaries of the research in terms of geographical focus, target demographics (e.g., age, socio-economic status), and industry sectors (e.g., healthcare IT).
3. Review Existing Literature and Resources
Literature Review: Conduct a thorough review of existing research, market reports, and relevant literature to build foundational knowledge.
Gap Analysis: Identify gaps in existing knowledge or areas where further exploration is needed.
4. Select Research Methodology and Tools
Methodological Approach: Choose appropriate research methods such as surveys, interviews, focus groups, or data analytics.
Tools and Resources: Select tools like Google Forms for surveys, analytics platforms (e.g., SimilarWeb, Statista), and expert consultations.
5. Ethical Considerations and Compliance
Ethical Approval: Ensure compliance with ethical guidelines for research involving human subjects.
Data Privacy: Implement measures to protect participant confidentiality and adhere to data protection regulations (e.g., GDPR, HIPAA).
6. Budget and Resource Allocation
Resource Planning: Allocate resources including time, budget, and personnel required for each phase of the research.
Contingency Planning: Anticipate and plan for unforeseen challenges or adjustments to the research plan.
7. Develop Research Instruments
Survey Design: Create well-structured surveys using tools like Google Forms to gather quantitative data.
Interview and Focus Group Guides: Prepare detailed scripts and discussion points for qualitative data collection.
8. Sampling Strategy
Sampling Design: Define the sampling frame, size, and method (e.g., random sampling, stratified sampling) to ensure representation of target demographics.
Participant Recruitment: Plan recruitment strategies to reach and engage the intended participant groups effectively.
9. Data Collection and Analysis Plan
Data Collection: Implement methods for data gathering, ensuring consistency and validity.
Analysis Techniques: Decide on analytical approaches (e.g., statistical
This particular slides consist of- what is Pneumothorax,what are it's causes and it's effect on body, risk factors, symptoms,complications, diagnosis and role of physiotherapy in it.
This slide is very helpful for physiotherapy students and also for other medical and healthcare students.
Here is a summary of Pneumothorax:
Pneumothorax, also known as a collapsed lung, is a condition that occurs when air leaks into the space between the lung and chest wall. This air buildup puts pressure on the lung, preventing it from expanding fully when you breathe. A pneumothorax can cause a complete or partial collapse of the lung.
CHAPTER 1 SEMESTER V COMMUNICATION TECHNIQUES FOR CHILDREN.pdfSachin Sharma
Here are some key objectives of communication with children:
Build Trust and Security:
Establish a safe and supportive environment where children feel comfortable expressing themselves.
Encourage Expression:
Enable children to articulate their thoughts, feelings, and experiences.
Promote Emotional Understanding:
Help children identify and understand their own emotions and the emotions of others.
Enhance Listening Skills:
Develop children’s ability to listen attentively and respond appropriately.
Foster Positive Relationships:
Strengthen the bond between children and caregivers, peers, and other adults.
Support Learning and Development:
Aid cognitive and language development through engaging and meaningful conversations.
Teach Social Skills:
Encourage polite, respectful, and empathetic interactions with others.
Resolve Conflicts:
Provide tools and guidance for children to handle disagreements constructively.
Encourage Independence:
Support children in making decisions and solving problems on their own.
Provide Reassurance and Comfort:
Offer comfort and understanding during times of distress or uncertainty.
Reinforce Positive Behavior:
Acknowledge and encourage positive actions and behaviors.
Guide and Educate:
Offer clear instructions and explanations to help children understand expectations and learn new concepts.
By focusing on these objectives, communication with children can be both effective and nurturing, supporting their overall growth and well-being.
The story of Dr. Ranjit Jagtap's daughters is more than a tale of inherited responsibility; it's a narrative of passion, innovation, and unwavering commitment to a cause greater than oneself. In Poulami and Aditi Jagtap, we see the beautiful continuum of a father's dream and the limitless potential of compassion-driven healthcare.
Fit to Fly PCR Covid Testing at our Clinic Near YouNX Healthcare
A Fit-to-Fly PCR Test is a crucial service for travelers needing to meet the entry requirements of various countries or airlines. This test involves a polymerase chain reaction (PCR) test for COVID-19, which is considered the gold standard for detecting active infections. At our travel clinic in Leeds, we offer fast and reliable Fit to Fly PCR testing, providing you with an official certificate verifying your negative COVID-19 status. Our process is designed for convenience and accuracy, with quick turnaround times to ensure you receive your results and certificate in time for your departure. Trust our professional and experienced medical team to help you travel safely and compliantly, giving you peace of mind for your journey.www.nxhealthcare.co.uk
The facial nerve, also known as cranial nerve VII, is one of the 12 cranial nerves originating from the brain. It's a mixed nerve, meaning it contains both sensory and motor fibres, and it plays a crucial role in controlling various facial muscles, as well as conveying sensory information from the taste buds on the anterior two-thirds of the tongue.
India Home Healthcare Market: Driving Forces and Disruptive Trends [2029]Kumar Satyam
According to the TechSci Research report titled "India Home Healthcare Market - By Region, Competition, Forecast and Opportunities, 2029," the India home healthcare market is anticipated to grow at an impressive rate during the forecast period. This growth can be attributed to several factors, including the rising demand for managing health issues such as chronic diseases, post-operative care, elderly care, palliative care, and mental health. The growing preference for personalized healthcare among people is also a significant driver. Additionally, rapid advancements in science and technology, increasing healthcare costs, changes in food laws affecting label and product claims, a burgeoning aging population, and a rising interest in attaining wellness through diet are expected to escalate the growth of the India home healthcare market in the coming years.
Browse over XX market data Figures spread through 70 Pages and an in-depth TOC on "India Home Healthcare Market”
https://www.techsciresearch.com/report/india-home-healthcare-market/15508.html
India Medical Devices Market: Size, Share, and In-Depth Competitive Analysis ...Kumar Satyam
According to TechSci Research report, “India Medical Devices Market Industry Size, Share, Trends, Competition, Opportunity and Forecast, 2019-2029,” the India Medical Devices Market was valued at USD 15.35 billion in 2023 and is anticipated to witness impressive growth in the forecast period, with a Compound Annual Growth Rate (CAGR) of 5.35% through 2029. This growth is driven by various factors, including strategic collaborations and partnerships among leading companies, a growing population, and the increasing demand for advanced healthcare solutions.
Recent Trends
Strategic Collaborations and Partnerships
One of the most significant trends driving the India Medical Devices Market is the increasing number of collaborations and partnerships among leading companies. These alliances aim to merge the expertise of individual companies to strengthen their market position and enhance their product offerings. For instance, partnerships between local manufacturers and international companies bring advanced technologies and manufacturing techniques to the Indian market, fostering innovation and improving product quality.
Browse over XX market data Figures and spread through XX Pages and an in-depth TOC on " India Medical Devices Market.” - https://www.techsciresearch.com/report/india-medical-devices-market/8161.html
Solution manual for managerial accounting 18th edition by ray garrison eric n...rightmanforbloodline
Solution manual for managerial accounting 18th edition by ray garrison eric noreen and peter brewer_compressed
Solution manual for managerial accounting 18th edition by ray garrison eric noreen and peter brewer_compressed
Data-Driven Dispensing- Rise of AI in Pharmacies.pdf
Antibiotics lecture
1. Emaneini M. PhD.
The Spectrum of Antimicrobial Activity
Narrow spectrum (limited spectrum)
Antimicrobials effective against a (limited spectrum)
of microbial types
A drug effective on G+ or G- bacteria
Broad spectrum (extended spectrum)
Antimicrobials effective against a (extended spectrum) wide
variety of microbial types
A drug effective against both G+& G- bacteria
2. Emaneini M. PhD.
The Action of Antimicrobial Drugs
Bactericidal
Kill microbes directly
Bacteriostatic
Prevent microbes from growing
4. Emaneini M. PhD.
1- Inhibition of Cell Wall Synthesis
2- Injuring the Plasma Membrane
3- Inhibition of Protein Synthesis
4- Inhibition of Nucleic Acid Synthesis
5- Inhibiting the Synthesis of Essential Metabolites
Mechanisms of Antibiotics Action
5. Emaneini M. PhD.
Inhibition of Cell Wall Synthesis
Transpeptidases, Carboxypeptidases, Transglycosylases
Penicillin-binding proteins (PBPs(
β-Lactam antibiotics: generally are bactericidal agents
7. Emaneini M. PhD.
Inhibition of Cell Wall Synthesis
Isoniazid, Ethionamide, Ethambutol, & Cycloserine
Used for the treatment of mycobacterial infections
Isoniazid
Isonicotinic acid hydrazide [INH])
Bactericidal; Blocks mycolic acid synthesis
Ethionamide
Derivative of INH
Blocks mycolic acid synthesis
Ethambutol
Interferes with the synthesis of arabinogalactan in the cell wall
Cycloserine
Inhibits D-alanine-Dalanine synthetase & Alanine racemase
10. Emaneini M. PhD.
Chloramphenicol
Broad spectrum
Bacteriostatic
Blocking peptide elongation
Binding reversibly to the peptidyl transferase (50S)
Only for the treatment of typhoid fever
Can produce aplastic anemia (1 per 24,000 treated patients)
Resistance: plasmid-encoded chloramphenicol acetyltransferase
12. Emaneini M. PhD.
Synthetic
Inhibit bacterial DNA gyrases (II) or topoisomerases (IV)
Nalidixic acid
Fluoroquinolones:
Ciprofloxacin Levofloxacin Gatifloxacin
Resistance: mutations in chromosomal genes of DNA gyrases (II)
or topoisomerases (IV)
Quinolones
13. Emaneini M. PhD.
Antimetabolites
Sulfonamides
Preventing the synthesis of the folic acid
Compete with p-aminobenzoic acid
Mammalian organisms do not synthesize folic acid
Treatment of Nocardia, Chlamydia, & some protozoa infections
Sulfacetamide Sulfadiazine Sulfisoxazole
R Group